Transgenomic to Raise $3M through Convertible Notes Offering | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic said today it has entered into an agreement to raise $3 million in convertible notes.

The Convertible Promissory Note Purchase Agreement was signed with investors associated with life sciences investment firm Third Security. The notes and the equity securities into which the notes can be converted have not been registered, but have been offered and sold in the US pursuant to exemptions from registration requirements, Transgenomic said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.